GC
BIVV

Globeflex Capital’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Globeflex Capital’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,810
Closed -$583K – 460
2017
Q4 		$583K Sell
10,810
-400
-4% -$21.9K 0.16% 213
2017
Q3 		$640K Buy
+11,210
New +$657K 0.18% 205

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Globeflex Capital's BIVV Position: Q1 2018 in Review

Globeflex Capital sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,810 shares — an estimated $583K sold.

Globeflex Capital first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $640K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Globeflex Capital reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Globeflex Capital sold 10,810 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $583K.
  • Globeflex Capital first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Globeflex Capital's Bioverativ Inc. Common Stock position peaked at $640K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Globeflex Capital's 13F filing for Q1 2018, filed 14 May 2018.